Bruno Julianne Insider Trades

Insider Trading History

Track insider trading activity for Bruno Julianne. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Galecto
Galecto GLTO
Director
Holding Value $0 0 shares
Last Trade
Feb 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.1k 129 shares
$24.00
$21.58
Galecto
Galecto GLTO
Director
Holding Value $2.96M 137,032 shares
Last Trade
Feb 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.1M 129,000 shares
$24.00
$21.58
Galecto
Galecto GLTO
Director
Holding Value $173k 8,032 shares
Last Trade
Nov 10, 2025 Sale
$2.19M 129,000 shares
$17.00
$21.58
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $532k 10,544 shares
Last Trade
Mar 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.7k 1,714 shares
$41.23
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $568k 11,250 shares
Last Trade
Mar 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$154k 3,750 shares
$41.17
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $619k 12,258 shares
Last Trade
Mar 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$154k 3,750 shares
$41.17
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $1.85M 36,666 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.54M 36,666 shares
$42.12
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $429k 8,508 shares
Last Trade
Mar 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.23k 190 shares
$43.32
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $439k 8,698 shares
Last Trade
Mar 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 435 shares
$42.37
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 435 shares
$42.37
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $417k 8,263 shares
Last Trade
Mar 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$50.8k 1,198 shares
$42.42
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $242k 4,796 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 2,399 shares
$43.34
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $477k 9,461 shares
Last Trade
Mar 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 2,399 shares
$43.34
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $356k 7,062 shares
Last Trade
Feb 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.6k 333 shares
$52.80
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $32.8k 650 shares
Last Trade
Feb 18, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 650 shares
$52.22
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $373k 7,395 shares
Last Trade
Feb 18, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 650 shares
$52.22
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $925k 18,333 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 18,333 shares
$49.00
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $340k 6,745 shares
Last Trade
Jun 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$189k 3,366 shares
$56.09
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Jun 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$417k 7,000 shares
$59.60
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Operating Officer
Holding Value $510k 10,111 shares
Last Trade
Jun 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$417k 7,000 shares
$59.60
$50.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up